|
2025-04-02 |
2025-03-31 |
V
Vente
|
FRATES JAMES M
Chief Financial Officer
Dirigeant
|
10 896
-3.6%
3,47
37 806 USD
|
10 896
-3.6%
|
3,47
|
37 806 USD
|
|
|
2025-04-02 |
2025-03-31 |
V
Vente
|
Mazzariello Gina
Chief Legal Officer
Dirigeant
|
9 192
-4.7%
3,48
31 954 USD
|
9 192
-4.7%
|
3,48
|
31 954 USD
|
|
|
2025-04-02 |
2025-03-31 |
V
Vente
|
Bedrosian Camille L
Chief Medical Officer
Dirigeant
|
12 425
-6.0%
3,47
43 082 USD
|
12 425
-6.0%
|
3,47
|
43 082 USD
|
|
|
2025-04-02 |
2025-03-31 |
V
Vente
|
Klee Justin B.
Co-Chief Executive Officer
Administrateur exécutif
|
21 490
-0.6%
3,46
74 454 USD
|
21 490
-0.6%
|
3,46
|
74 454 USD
|
|
|
2025-04-02 |
2025-03-31 |
V
Vente
|
Cohen Joshua B
Co-Chief Executive Officer
Administrateur exécutif
|
21 490
-0.6%
3,47
74 482 USD
|
21 490
-0.6%
|
3,47
|
74 482 USD
|
|
|
2025-03-24 |
2025-03-20 |
A
Achat
|
Zeiher Bernhardt G
Administrateur non-exécutif
|
10 000
+inf%
3,70
37 005 USD
|
10 000
+inf%
|
3,70
|
37 005 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Cohen Joshua B
Co-Chief Executive Officer
Administrateur exécutif
|
4 595
-0.1%
3,17
14 549 USD
|
4 595
-0.1%
|
3,17
|
14 549 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Klee Justin B.
Co-Chief Executive Officer
Administrateur exécutif
|
4 595
-0.1%
3,15
14 483 USD
|
4 595
-0.1%
|
3,15
|
14 483 USD
|
|
|
2025-03-05 |
2025-03-03 |
V
Vente
|
Mazzariello Gina
Chief Legal Officer
Dirigeant
|
1 611
-1.2%
3,12
5 022 USD
|
1 611
-1.2%
|
3,12
|
5 022 USD
|
|
|
2025-02-26 |
2025-02-24 |
V
Vente
|
Mazzariello Gina
Chief Legal Officer
Dirigeant
|
4 169
-3.0%
3,15
13 145 USD
|
4 169
-3.0%
|
3,15
|
13 145 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Klee Justin B.
Co-Chief Executive Officer
Administrateur exécutif
|
11 855
-0.4%
3,47
41 104 USD
|
11 855
-0.4%
|
3,47
|
41 104 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Cohen Joshua B
Co-Chief Executive Officer
Administrateur exécutif
|
11 851
-0.4%
3,47
41 108 USD
|
11 851
-0.4%
|
3,47
|
41 108 USD
|
|
|
2025-02-05 |
2025-02-03 |
V
Vente
|
Mazzariello Gina
Chief Legal Officer
Dirigeant
|
3 678
-2.6%
3,49
12 839 USD
|
3 678
-2.6%
|
3,49
|
12 839 USD
|
|
|
2025-01-08 |
2025-01-06 |
V
Vente
|
Klee Justin B.
Co-Chief Executive Officer
Administrateur exécutif
|
7 471
-0.2%
4,04
30 202 USD
|
7 471
-0.2%
|
4,04
|
30 202 USD
|
|
|
2025-01-08 |
2025-01-06 |
V
Vente
|
Cohen Joshua B
Co-Chief Executive Officer
Administrateur exécutif
|
7 471
-0.2%
4,05
30 232 USD
|
7 471
-0.2%
|
4,05
|
30 232 USD
|
|
|
2024-12-03 |
2024-12-02 |
V
Vente
|
Bedrosian Camille L
Chief Medical Officer
Dirigeant
|
5 421
-3.8%
5,54
30 007 USD
|
5 421
-3.8%
|
5,54
|
30 007 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Mazzariello Gina
Chief Legal Officer
Dirigeant
|
8 709
-5.7%
3,20
27 840 USD
|
8 709
-5.7%
|
3,20
|
27 840 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Bedrosian Camille L
Chief Medical Officer
Dirigeant
|
11 442
-7.4%
3,20
36 559 USD
|
11 442
-7.4%
|
3,20
|
36 559 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Klee Justin B.
Co-Chief Executive Officer
Administrateur exécutif
|
18 589
-0.6%
3,20
59 429 USD
|
18 589
-0.6%
|
3,20
|
59 429 USD
|
|
|
2024-10-02 |
2024-09-30 |
V
Vente
|
Cohen Joshua B
Co-Chief Executive Officer
Administrateur exécutif
|
18 589
-0.6%
3,20
59 414 USD
|
18 589
-0.6%
|
3,20
|
59 414 USD
|
|
